NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · IEX Real-Time Price · USD
2.100
+0.040 (1.94%)
At close: May 3, 2024, 4:00 PM
2.240
+0.140 (6.67%)
After-hours: May 3, 2024, 7:21 PM EDT

NRx Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current2023202220212020201920182017
Market Capitalization
22397528166649264
Market Cap Growth
--48.59%-73.29%328.57%1.96%-30.20%44.80%-
Enterprise Value
27436625465679363
PE Ratio
-1.28-1.28-1.89-0.81-1.27-9.561394.26-605.96
PB Ratio
-3.29-3.2910.1313.51-1.50-13.2618.4312.73
P/FCF Ratio
-1.78-1.78-1.89-7.45-28.93-11.60-194.77-468.65
P/OCF Ratio
-1.78-1.78-1.89-7.46-28.96-11.61-194.77-468.65
EV/EBITDA Ratio
-1.44-1.44-1.65-2.73-1.25-10.461126.55-601.68
EV/EBIT Ratio
-1.44-1.44-1.65-2.73-1.25-10.461126.55-601.68
EV/FCF Ratio
-1.99-1.99-1.65-6.74-28.47-12.12-196.20-465.34
Debt / Equity Ratio
-0.78-0.781.420.02-0.02-0.770.14-
Debt / EBITDA Ratio
-0.31-0.31-0.26-0.01-0.02-0.588.37-
Debt / FCF Ratio
-0.42-0.42-0.26-0.01-0.35-0.68-1.46-
Quick Ratio
0.240.241.292.320.060.370.024.82
Current Ratio
0.360.361.662.740.060.410.055.76
Interest Coverage
-250.25-250.25--5169.17-923.59-21.20--
Return on Equity (ROE)
573.30%573.30%-195.80%34059.90%624.40%-265.20%1.30%-
Return on Assets (ROA)
-194.50%-194.50%-125.50%-1267.50%-965.90%-16.40%0.10%-
Return on Capital (ROIC)
1082.31%1082.31%-247.21%-543.03%119.58%566.96%-14.19%-2.69%
Earnings Yield
-136.06%-78.13%-52.95%-124.11%-78.94%-10.46%0.07%-0.17%
FCF Yield
-97.72%-56.11%-52.96%-13.41%-3.46%-8.62%-0.51%-0.21%
Buyback Yield / Dilution
-15.20%-15.20%-40.17%-36.90%-220.58%-308.88%-38.42%-
Total Shareholder Return
-15.20%-15.20%-40.17%-36.90%-220.58%-308.88%-38.42%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).